Compare Packaging Corporation of America (PKG) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Regeneron Pharmaceuticals Inc — how do they compare? Packaging Corporation of America trades at $231.22 (market cap $20.49B), while Regeneron Pharmaceuticals Inc trades at $740 (market cap $76.14B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.7× Packaging Corporation of America's market cap, and Packaging Corporation of America pays the higher dividend (2.61%). Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.
| PKG | REGN | |
|---|---|---|
Market Cap | $20.49B | $76.14B |
Volume | 493,499 | 500,239 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $852.03 |
52-Week Low | $191.68 | $557.73 |
Typical Hold Time | 45 Days | 107 Days |
Enterprise Value | $24.30B | $70.85B |
Dividend Yield | 2.61% | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $227.25, down 1.08% on the day, amid a bearish technical signal. The stock shows mixed earnings performance, with Q2 2026 beating estimates but net income margin projected to decline in 2026. Analyst consensus is a Buy with a $272.43 price target, though technical indicators suggest near-term pressure with support at $225.
PKG offers a stable dividend and benefits from consistent packaging demand, but faces headwinds from cost pressures and negative cash flow. Investment appeal hinges on execution against margin challenges and the upcoming Q3 earnings report. Risks include rising input costs and competitive pressures in the industrial packaging sector.
Regeneron Pharmaceuticals (REGN) trades at $742.12, up 0.46% on the day, with a bearish technical signal despite strong fundamentals. The stock shows robust profitability with a 27.86% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront and milestone payments.
The outlook is positive due to strong earnings momentum and strategic collaborations, but risks include competitive pressures in key drug markets and technical bearish indicators. Analyst consensus is bullish with a $849.84 price target, suggesting potential upside from current levels, though investors should monitor execution of new partnerships and pipeline developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
